Add BrightSurf on Google Email

Fighting brain cancer at its root

Researchers at McGill University identified proteins that drive cancer stem cells in brain tumours. Targeting the protein galectin1 may provide a more effective treatment for glioblastoma when combined with radiation therapy. The study found significant improvement in tumour response to radiation therapy, resulting in expanded lifespan.

SourceMcGill University·JournalCell Reports·TypeExperimental study·DateAug 31, 2021

First 3D-bioprinting of entire active tumor

Researchers at Tel Aviv University successfully printed the first entirely active and viable glioblastoma tumor using a 3D printer. The 3D-bioprinted model includes functional blood vessels that simulate a real tumor, making it a promising tool for predicting treatment efficacy and drug development.

SourceTel-Aviv University·JournalScience Advances·DateAug 18, 2021

Polymeric nanomicelles improve internalization of lipid metabolism modulators in brain cells

Researchers have developed poly-ion complex (PIC) nanomicelles loaded with CPT1A inhibitors to deliver drugs into brain cells, reducing fatty acid oxidation and improving treatment for glioblastoma. The delivery system successfully increased cellular concentration of the cargo and biological activity.

SourceInnovation Center of NanoMedicine·JournalBiomaterials Science·TypeExperimental study·DateAug 3, 2021

Looking at tumors through a new lens

A new study reveals similarities between glioblastoma and melanoma, as well as unique immunosuppressive factors specific to glioblastoma microenvironment. This framework can be used to uncover pathophysiological and molecular features that determine the effectiveness of immunotherapies.

SourceInstitute for Systems Biology·JournalNature Communications·DateJun 29, 2021

Chemo for glioblastoma may work better in morning than evening

Researchers at WashU Medicine found that administering chemotherapy drug temozolomide in the morning improved overall survival by about 4 months compared to evening, with an average increase of 3.5 months in patients with MGMT methylated tumors. The study suggests that adjusting timing of standard treatment could enhance effectiveness.

SourceWashU Medicine·JournalNeuro-Oncology Advances·DateMar 31, 2021

Combination therapy with radiation shows promise in treating glioblastoma

Researchers at UCLA Jonsson Comprehensive Cancer Center identified a new approach combining an anti-psychotic drug, a statin and radiation to improve overall survival in mice with glioblastoma. The triple combination extended median survival 4-fold compared to radiation alone, providing hope for improved treatment options.

SourceUniversity of California - Los Angeles Health Sciences·JournalJNCI Journal of the National Cancer Institute·DateFeb 9, 2021

Imaging can guide whether liquid biopsy will benefit individual glioblastoma patients

A new Penn study found that imaging techniques, such as MRI, may help identify which glioblastoma patients are best candidates for liquid biopsies. The research showed a correlation between the blood-brain barrier and macrophage density with circulating DNA levels, suggesting the potential for personalized treatment decisions.

SourceUniversity of Pennsylvania School of Medicine·JournalNeuro-Oncology Advances·DateFeb 27, 2020